Intraosseous vancomycin results in lower superficial and deep infection rate compared with alternative intravenous methods in total knee arthroplasty: a time-stratified meta-analysis
Related Experiment Video
Updated: Apr 28, 2026

Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection
Published on: March 14, 2019
Fardis Vosoughi1, Diako Seyedi2, Parnian Rahnama2
1Department of Orthopaedics and Trauma Surgery, Shariati Hospital, Tehran University Of Medical Sciences, Tehran, Iran.
Background:
Periprosthetic joint infection (PJI) remains a challenging complication in total joint arthroplasty (TJA), and concerns about antimicrobial resistance in intravenous (IV) vancomycin have renewed interest in intraosseous (IO) prophylaxis. This meta-analysis compares IO vancomycin versus IV prophylaxis in TJA with respect to overall and time-stratified PJI, organism-specific infections, wound complications, revision rates, pharmacokinetics, acute kidney injury (AKI), and deep vein thrombosis (DVT).
Methods:
A systematic review and meta-analysis were conducted, including clinical studies of adults undergoing total knee arthroplasty (TKA) or total hip arthroplasty (THA) that compared IO vancomycin with alternative IV methods. Outcomes were pooled using random-effects models and stratified by follow up intervals (30 days, 90 days, and 1 year).
Results:
Of the 13 included studies, 12 investigated TKA, comprising 6876 cases (51.6% IO group). Vancomycin concentration was significantly higher in IO group in both femoral bone and fat tissue (standardized mean difference (SMD): 0.61, 95% confidence interval (CI): 0.09-1.12; SMD: 1.53, 95% CI: 0.43-2.62, respectively). Regarding primary TKA cases, IO administration significantly reduced overall PJI (risk ratio (RR): 0.35, 95% CI: 0.17-0.72), with consistent significance at 30-day and 1-year follow up. Gram-positive infections decreased significantly (RR: 0.37, 95% CI: 0.17-0.82), whereas Gram-negative infections were comparable. Non-operative wound complications were significantly lower (RR: 0.50, 95% CI: 0.32-0.80). However, reoperation-requiring wound complications, AKI, DVT, or revision rates were comparable. Regarding revision TKA, the IO group demonstrated a significantly lower rate of non-operative wound complications (RR: 0.23) and a favorable but nonsignificant reduction in PJI.
Conclusions:
IO vancomycin prophylaxis provides substantially higher local antibiotic concentrations, lower rates of PJI and superficial wound complications without increasing renal, thrombotic, and revision risk in primary TKA.
Insights
Intraosseous (IO) vancomycin prophylaxis in total knee arthroplasty (TKA) significantly lowers periprosthetic joint infection (PJI) and wound complication rates. This method achieves higher local antibiotic levels without increasing risks of kidney injury, blood clots, or revision surgery.
Area of Science:
- Orthopedic Surgery
- Infectious Disease
- Pharmacology
Background:
- Periprosthetic joint infection (PJI) is a significant complication following total joint arthroplasty (TJA).
- Concerns regarding antimicrobial resistance to intravenous (IV) vancomycin have prompted investigation into alternative prophylaxis methods.
- Intraosseous (IO) vancomycin is being explored as a potentially more effective prophylactic agent in TJA.
Purpose of the Study:
- To compare the efficacy and safety of intraosseous (IO) vancomycin versus intravenous (IV) prophylaxis in total joint arthroplasty (TJA).
- To evaluate outcomes including periprosthetic joint infection (PJI), organism-specific infections, wound complications, revision rates, pharmacokinetics, acute kidney injury (AKI), and deep vein thrombosis (DVT).
Main Methods:
- A systematic review and meta-analysis of clinical studies involving adults undergoing total knee arthroplasty (TKA) or total hip arthroplasty (THA).
- Studies compared IO vancomycin with alternative IV prophylaxis methods.
- Outcomes were analyzed using random-effects models and stratified by follow-up intervals (30 days, 90 days, 1 year).
Main Results:
- Intraosseous vancomycin resulted in significantly higher vancomycin concentrations in bone and fat tissue compared to IV administration.
- IO vancomycin significantly reduced overall PJI and Gram-positive infections in primary TKA cases.
- Non-operative wound complications were significantly lower with IO vancomycin, while rates of reoperation-requiring complications, AKI, DVT, and revision were comparable between groups.
Conclusions:
- Intraosseous vancomycin prophylaxis demonstrates superior local antibiotic concentrations compared to IV administration.
- IO vancomycin significantly reduces the incidence of PJI and superficial wound complications in primary TKA.
- This method does not elevate the risk of renal complications, thrombotic events, or revision surgery.
Related Concept Videos
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Estimation of k and VD of Aminoglycosides

